Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on the Long-Term Outcome after Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation | Zendy

Hanno U. Klemm | Zendy; Thomas Heitzer | Zendy; Ute Ruprecht | Zendy; Thomas Meinertz | Zendy; Rodolfo Ventura | Zendy

Open Access

Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on the Long-Term Outcome after Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation

Author(s) -

Hanno U. Klemm,

Thomas Heitzer,

Ute Ruprecht,

Thomas Meinertz,

Rodolfo Ventura

Publication year - 2010

Publication title -

cardiology

Language(s) - English

Resource type - Journals

eISSN - 1421-9751

pISSN - 0008-6312

DOI - 10.1159/000318016

Subject(s) - pulmonary vein , medicine , paroxysmal atrial fibrillation , cardiology , atrial fibrillation , sinus rhythm , ablation , angiotensin converting enzyme , angiotensin receptor blockers , angiotensin receptor , propensity score matching , angiotensin ii , renin–angiotensin system , receptor , blood pressure

The effect of angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin II receptor blockers (ARBs) on the long-term outcome after pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation (PAF) is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research